Hodgkin's Risk Doubles In Women Who Smoke

Women who smoke are doubling their risk of developing Hodgkin's lymphoma and raising their risk of developing other blood-based cancers, say researchers out of Cancer Research UK, the largest cancer charity in the United Kingdom.

The findings, published in the British Journal of Cancer, are meant to influence a governmental decision about standardizing cigarette packaging in size, shape and color so as to limit the potential appeal of cigarette smoking to younger people.

Cancer Research UK director of tobacco control Jean King said,

"We urge the government to respond as quickly as possible to stop another generation from becoming addicted to a product that will kill half of all long-term smokers.”

Million Women study data used

Researchers reached their conclusions after drawing out data from the decade-long "Million Women" study. In addition to Hodgkin's lymphoma, the study found that women who smoke a pack a day were also at risk for leukemia, multiple myeloma and other blood disorders.

While in general the UK public is aware of the association between smoking and lung cancer as well as mouth and throat cancer, but a much smaller percentage of the public is aware of the growing association between smoking and cancers of the liver, pancreas, bowel, kidney, cervix, bladder, and lymphatic system.

Cigarette packaging addressed

For this reason, advocates at Cancer Research UK stress the need to downplay the packaging on cigarettes to discourage young people from starting the habit.

“These results highlight yet again how important smoking is as a cause of cancer," said study co-author Professor Valerie Beral. "Smoking raises the risk of many types of cancer, not just lung cancer, and also the risk of heart attack and stroke, which many people may not be aware of.”

Source: OnMedica

Photo by John Nyboer

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap